rs397516409
Variant summary
Our verdict is Likely pathogenic. The variant received 7 ACMG points: 7P and 0B. PM1PM2PP2PP3_Moderate
The NM_000432.4(MYL2):c.82G>A(p.Glu28Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/23 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E28D) has been classified as Uncertain significance.
Frequency
Consequence
NM_000432.4 missense
Scores
Clinical Significance
Conservation
Publications
- hypertrophic cardiomyopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- hypertrophic cardiomyopathy 10Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- myopathy, myofibrillar, 12, infantile-onset, with cardiomyopathyInheritance: AR Classification: MODERATE Submitted by: Ambry Genetics
- congenital fiber-type disproportion myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- dilated cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
- arrhythmogenic right ventricular cardiomyopathyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 7 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MYL2 | NM_000432.4 | c.82G>A | p.Glu28Lys | missense_variant | Exon 2 of 7 | ENST00000228841.15 | NP_000423.2 | |
| MYL2 | NM_001406745.1 | c.82G>A | p.Glu28Lys | missense_variant | Exon 2 of 6 | NP_001393674.1 | ||
| MYL2 | NM_001406916.1 | c.25G>A | p.Glu9Lys | missense_variant | Exon 2 of 7 | NP_001393845.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MYL2 | ENST00000228841.15 | c.82G>A | p.Glu28Lys | missense_variant | Exon 2 of 7 | 1 | NM_000432.4 | ENSP00000228841.8 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Pathogenic. The Glu28Lys va riant in MYL2 has not been reported in the literature nor previously identified in >2300 individuals (>1400 Caucasian) tested by our laboratory. This low freque ncy supports a pathogenic role. Glutamic acid (Glu) at position 28 is highly con served in mammals and across evolutionarily distant species and the change to Ly sine (Lys) was predicted to be pathogenic using a computational tool, which was validated by our laboratory using a set of cardiomyopathy variants with well-est ablished clinical significance. This tool's pathogenic prediction is estimated t o be correct 94% of the time (Jordan 2011). Although this data suggests that the Glu28Lys variant may be pathogenic, additional studies are needed to fully asse ss its clinical significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at